UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Upregulated Expression of ERBB2/HER2 in Multiple Myeloma as a Predictor of Poor Survival Outcomes

International journal of molecular sciences, 2023-06, Vol.24 (12), p.9943

2023

Volltextzugriff (PDF)

Realizing the Potential for Recipient Immune Cells in Adoptive Immune Therapy

EBioMedicine, 2016-08, Vol.10 (C), p.11-12

Qazi, Sanjive

2016

Volltextzugriff (PDF)

CD22 Exon 12 Deletion as an Independent Predictor of Poor Treatment Outcomes in B-ALL

Cancers, 2023-03, Vol.15 (5), p.1599

2023

Volltextzugriff (PDF)

Transforming Growth Factor Beta 2 (TGFB2) mRNA Levels, in Conjunction with Interferon-Gamma Receptor Activation of Interferon Regulatory Factor 5 (IRF5) and Expression of CD276/B7-H3, Are Therapeutically Targetable Negative Prognostic Markers in Low-Grade Gliomas

Cancers, 2024-03, Vol.16 (6), p.1202

2024

Volltextzugriff (PDF)

High Intra-Tumor Transforming Growth Factor Beta 2 Level as a Predictor of Poor Treatment Outcomes in Pediatric Diffuse Intrinsic Pontine Glioma

Cancers, 2023-03, Vol.15 (6), p.1676

2023

Volltextzugriff (PDF)

Transforming Growth Factor Beta 2 (TGFB2) and Interferon Gamma Receptor 2 (IFNGR2) mRNA Levels in the Brainstem Tumor Microenvironment (TME) Significantly Impact Overall Survival in Pediatric DMG Patients

Biomedicines, 2024-01, Vol.12 (1), p.191

2024

Volltextzugriff (PDF)

Upregulated Expression of ErbB1 in Diffuse Large B-Cell Lymphoma as a Predictor of Poor Overall Survival Outcome

Journal of personalized medicine, 2023-04, Vol.13 (5), p.770

2023

Volltextzugriff (PDF)

ERBB1/EGFR and JAK3 Tyrosine Kinases as Potential Therapeutic Targets in High-Risk Multiple Myeloma

Onco, 2022-12, Vol.2 (4), p.282-304

2022

Volltextzugriff (PDF)

Serine phosphorylation by SYK is critical for nuclear localization and transcription factor function of Ikaros

Proceedings of the National Academy of Sciences - PNAS, 2012-10, Vol.109 (44), p.18072-18077

2012

Volltextzugriff (PDF)

A Phase 1B Clinical Study of Combretastatin A1 Diphosphate (OXi4503) and Cytarabine (ARA-C) in Combination (OXA) for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Cancers, 2019-12, Vol.12 (1), p.74

2019

Volltextzugriff (PDF)

STAT3 is a substrate of SYK tyrosine kinase in B-lineage leukemia/lymphoma cells exposed to oxidative stress

Proceedings of the National Academy of Sciences - PNAS, 2010-02, Vol.107 (7), p.2902-2907

2010

Volltextzugriff (PDF)

TMIC-85. TGFB2 AND IFNGR2 MRNA EXPRESSION LEVELS IN THE TUMOR MICROENVIRONMENT (TME) PROGNOSITICALLY IMPACT OS IN PEDIATRIC DIPG PATIENTS

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v297-v298

2023

Volltextzugriff (PDF)

How functional traits, herbivory, and genetic diversity interact in Echinacea: implications for fragmented populations

Ecology (Durham), 2015-07, Vol.96 (7), p.1877-1886

2015

Volltextzugriff (PDF)

CD22 EXON 12 deletion as a pathogenic mechanism of human B-precursor leukemia

Proceedings of the National Academy of Sciences - PNAS, 2010-09, Vol.107 (39), p.16852-16857

2010

Volltextzugriff (PDF)

Contemporary patient-tailored treatment strategies against high risk and relapsed or refractory multiple myeloma

EBioMedicine, 2019-01, Vol.39, p.612-620

2019

Volltextzugriff (PDF)

Incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia

Haematologica (Roma), 2013-12, Vol.98 (12), p.e151-e152

2013

Volltextzugriff (PDF)

Regulatory phosphorylation of Ikaros by Bruton's tyrosine kinase

PloS one, 2013-08, Vol.8 (8), p.e71302-e71302

2013

Volltextzugriff (PDF)

Constitutive function of the Ikaros transcription factor in primary leukemia cells from pediatric newly diagnosed high-risk and relapsed B-precursor ALL patients

PloS one, 2013-11, Vol.8 (11), p.e80732

2013

Volltextzugriff (PDF)

A rationally designed nanoparticle for RNA interference therapy in B-lineage lymphoid malignancies

EBioMedicine, 2014-12, Vol.1 (2-3), p.141-155

2014

Volltextzugriff (PDF)

Liposomal Nanoparticles of a Spleen Tyrosine Kinase P-Site Inhibitor Amplify the Potency of Low Dose Total Body Irradiation Against Aggressive B-Precursor Leukemia and Yield Superior Survival Outcomes in Mice

EBioMedicine, 2015-06, Vol.2 (6), p.554-562

2015

Volltextzugriff (PDF)

Transforming Growth Factor Beta 2 and Expression of CD276/B7-H3, Are Therapeutically Targetable Negative Prognostic Markers in Low-Grade Gliomas

Cancers, 2024-03, Vol.16 (6)

2024

Volltextzugriff (PDF)

Anti-breast cancer activity of LFM-A13, a potent inhibitor of Polo-like kinase (PLK)

Bioorganic & medicinal chemistry, 2007-01, Vol.15 (2), p.800-814

2007

Volltextzugriff (PDF)

Meta-analysis comparing the incidence of serious adverse events, overall survival, and progression-free survival in patients with pancreatic adenocarcinoma harboring unresectable tumors treated with modified FOLFIRINOX or FOLFIRINOX regimen

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e16318-e16318

2024

Volltextzugriff (PDF)

A Previously Unknown Unique Challenge for Inhibitors of SYK ATP-Binding Site: Role of SYK as A Cell Cycle Checkpoint Regulator

EBioMedicine, 2014-11, Vol.1 (1), p.16-28

2014

Volltextzugriff (PDF)

Low Dose Total Body Irradiation Combined With Recombinant CD19-Ligand×Soluble TRAIL Fusion Protein is Highly Effective Against Radiation-resistant B-precursor Acute Lymphoblastic Leukemia in Mice

EBioMedicine, 2015-04, Vol.2 (4), p.306-316

2015

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(127)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Arzneimittel-Forschung
(18)
British Journal Of Haematology
(9)
Cancers
(7)
Ebiomedicine
(7)
Cancer Research
(5)
Cheminform
(4)
Integrative Biology
(4)
Journal Of Clinical Oncology
(4)
Neuro-Oncology
(4)
Antimicrobial Agents And Chemotherapy
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Upregulated Expression of ERBB2/HER2 in Multiple Myeloma as a Predictor of Poor Survival Outcomes

Realizing the Potential for Recipient Immune Cells in Adoptive Immune Therapy

CD22 Exon 12 Deletion as an Independent Predictor of Poor Treatment Outcomes in B-ALL

Transforming Growth Factor Beta 2 (TGFB2) mRNA Levels, in Conjunction with Interferon-Gamma Receptor Activation of Interferon Regulatory Factor 5 (IRF5) and Expression of CD276/B7-H3, Are Therapeutically Targetable Negative Prognostic Markers in Low-Grade Gliomas

High Intra-Tumor Transforming Growth Factor Beta 2 Level as a Predictor of Poor Treatment Outcomes in Pediatric Diffuse Intrinsic Pontine Glioma

Transforming Growth Factor Beta 2 (TGFB2) and Interferon Gamma Receptor 2 (IFNGR2) mRNA Levels in the Brainstem Tumor Microenvironment (TME) Significantly Impact Overall Survival in Pediatric DMG Patients

Upregulated Expression of ErbB1 in Diffuse Large B-Cell Lymphoma as a Predictor of Poor Overall Survival Outcome

ERBB1/EGFR and JAK3 Tyrosine Kinases as Potential Therapeutic Targets in High-Risk Multiple Myeloma

Serine phosphorylation by SYK is critical for nuclear localization and transcription factor function of Ikaros

A Phase 1B Clinical Study of Combretastatin A1 Diphosphate (OXi4503) and Cytarabine (ARA-C) in Combination (OXA) for Patients with Relapsed or Refractory Acute Myeloid Leukemia

STAT3 is a substrate of SYK tyrosine kinase in B-lineage leukemia/lymphoma cells exposed to oxidative stress

TMIC-85. TGFB2 AND IFNGR2 MRNA EXPRESSION LEVELS IN THE TUMOR MICROENVIRONMENT (TME) PROGNOSITICALLY IMPACT OS IN PEDIATRIC DIPG PATIENTS

How functional traits, herbivory, and genetic diversity interact in Echinacea: implications for fragmented populations

CD22 EXON 12 deletion as a pathogenic mechanism of human B-precursor leukemia

Contemporary patient-tailored treatment strategies against high risk and relapsed or refractory multiple myeloma

Incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia

Regulatory phosphorylation of Ikaros by Bruton's tyrosine kinase

Constitutive function of the Ikaros transcription factor in primary leukemia cells from pediatric newly diagnosed high-risk and relapsed B-precursor ALL patients

A rationally designed nanoparticle for RNA interference therapy in B-lineage lymphoid malignancies

Liposomal Nanoparticles of a Spleen Tyrosine Kinase P-Site Inhibitor Amplify the Potency of Low Dose Total Body Irradiation Against Aggressive B-Precursor Leukemia and Yield Superior Survival Outcomes in Mice

Transforming Growth Factor Beta 2 and Expression of CD276/B7-H3, Are Therapeutically Targetable Negative Prognostic Markers in Low-Grade Gliomas

Anti-breast cancer activity of LFM-A13, a potent inhibitor of Polo-like kinase (PLK)

Meta-analysis comparing the incidence of serious adverse events, overall survival, and progression-free survival in patients with pancreatic adenocarcinoma harboring unresectable tumors treated with modified FOLFIRINOX or FOLFIRINOX regimen

A Previously Unknown Unique Challenge for Inhibitors of SYK ATP-Binding Site: Role of SYK as A Cell Cycle Checkpoint Regulator

Low Dose Total Body Irradiation Combined With Recombinant CD19-Ligand×Soluble TRAIL Fusion Protein is Highly Effective Against Radiation-resistant B-precursor Acute Lymphoblastic Leukemia in Mice

Suchergebnisse filtern